IN2012DN03128A - - Google Patents

Download PDF

Info

Publication number: IN2012DN03128A
Authority: IN; India
Prior art keywords: compositions; eye; active ingredient; treatment; group
Prior art date: 2009-12-14

Application number

Other languages

English (en)

Inventor

Bastian Theisinger

Sonja Theisinger

Bernhard Gunther

Original Assignee

Novaliq Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-14

Filing date

2010-12-13

Publication date

2015-09-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41731659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN03128(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-12-13 Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh

2015-09-18 Publication of IN2012DN03128A publication Critical patent/IN2012DN03128A/en

Links

239000000203 mixture Substances 0.000 abstract 2
208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
206010013774 Dry eye Diseases 0.000 abstract 1
208000009319 Keratoconjunctivitis Sicca Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
150000001335 aliphatic alkanes Chemical class 0.000 abstract 1
229960003444 immunosuppressant agent Drugs 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IN3128DEN2012 2009-12-14 2010-12-13 IN2012DN03128A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP09015423A EP2335735A1 (fr)	2009-12-14	2009-12-14	Composition pharmaceutique pour le traitement de la kératoconjonctivite sèche
PCT/EP2010/069495 WO2011073134A1 (fr)	2009-12-14	2010-12-13	Composition pharmaceutique pour le traitement du syndrome de l'oeil sec

Publications (1)

Publication Number	Publication Date
IN2012DN03128A true IN2012DN03128A (fr)	2015-09-18

Family

ID=41731659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN3128DEN2012 IN2012DN03128A (fr)	2009-12-14	2010-12-13

Country Status (15)

Country	Link
US (1)	US8614178B2 (fr)
EP (2)	EP2335735A1 (fr)
JP (5)	JP5663595B2 (fr)
KR (2)	KR101722039B1 (fr)
CN (1)	CN102652022B (fr)
AU (1)	AU2010333039B2 (fr)
BR (3)	BR112012014190B8 (fr)
CA (2)	CA2776860C (fr)
DK (1)	DK2512515T3 (fr)
ES (1)	ES2449308T3 (fr)
IN (1)	IN2012DN03128A (fr)
MX (1)	MX2012006720A (fr)
PL (1)	PL2512515T3 (fr)
PT (1)	PT2512515E (fr)
WO (1)	WO2011073134A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2010256558B2 (en)	2009-06-03	2013-10-03	Forsight Labs, Llc	Anterior segment drug delivery
ES2564502T3 (es)	2010-03-17	2016-03-23	Novaliq Gmbh	Composición farmacéutica para el tratamiento de la presión intraocular aumentada
EP2444063A1 (fr)	2010-10-20	2012-04-25	Novaliq GmbH	Compositions pharmaceutiques liquides pour l'administration de principes actifs
EP2462921A1 (fr)	2010-11-11	2012-06-13	Novaliq GmbH	Compositions pharmaceutiques liquides pour le traitement d'une maladie de la chambre postérieure de l'oeil
JP6039145B2 (ja)	2011-05-25	2016-12-07	ノバリックゲーエムベーハー	半フッ化アルカンを基礎にした局所薬学的組成物
JP6023181B2 (ja)	2011-05-25	2016-11-09	ノバリックゲーエムベーハー	爪に投与するための医薬組成物
CN104066442B (zh)	2012-01-23	2018-05-18	诺瓦利克有限责任公司	基于半氟化烷烃的稳定蛋白质组合物
EP2708228B1 (fr)	2012-09-12	2018-05-16	Novaliq GmbH	Compositions de lavage oculaire
MX360469B (es) *	2012-09-12	2018-11-05	Novaliq Gmbh	Composiciones que comprenden mezclas de alcanos semifluorados.
DE202013012753U1 (de) *	2012-09-12	2019-03-04	Novaliq Gmbh	Zusammensetzungen semifluorierter Alkane zur Verwendung in der Behandlung von Keratoconjunctivitis Sicca
EP2730291A1 (fr) *	2012-11-09	2014-05-14	Fluoron Gmbh	Composition de tamponnade interne
DK2948134T3 (da)	2013-01-24	2020-06-02	Palvella Therapeutics Inc	Sammensætninger til transdermal indgivelse af mtor-inhibitorer
JP6304475B2 (ja) *	2013-01-31	2018-04-04	ロート製薬株式会社	点眼剤
US20160022648A1 (en) *	2013-03-13	2016-01-28	Santen Pharmaceutical Co., Ltd.	Therapeutic agent for meibomian gland dysfunction
WO2015011199A1 (fr)	2013-07-23	2015-01-29	Novaliq Gmbh	Compositions d'anticorps stabilisées
EP3057514A4 (fr) *	2013-10-15	2017-08-02	Forsight Vision5, Inc.	Préparations et méthodes permettant d'augmenter ou de réduire le mucus
US20200237859A1 (en)	2019-01-25	2020-07-30	Newport Research, Inc.	Aqueous suspensions of cyclosporin
US11324800B2 (en)	2015-01-15	2022-05-10	Wellspring Ophthalmics, Inc.	Aqueous suspensions of cyclosporin
US20160296532A1 (en)	2015-04-13	2016-10-13	Forsight Vision5, Inc.	Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US11013403B2 (en) *	2015-09-29	2021-05-25	The Regents Of The University Of California	Methods of diagnosing diseases of mucosal surfaces
CN120884568A (zh)	2015-09-30	2025-11-04	诺瓦利克有限责任公司	半氟化化合物和其组合物
ES2953837T3 (es) *	2015-09-30	2023-11-16	Novaliq Gmbh	2-perfluorobutil pentano para administración oftálmica
EP3442480B1 (fr)	2016-06-23	2019-10-02	Novaliq GmbH	Méthode d'administration topique
US11684589B2 (en)	2016-09-22	2023-06-27	Novaliq Gmbh	Pharmaceutical compositions for use in the therapy of blepharitis
JP6869336B2 (ja) *	2016-09-23	2021-05-12	ノバリックゲーエムベーハー	シクロスポリンを含む眼科用組成物
EP3698785A1 (fr) *	2016-09-28	2020-08-26	Novaliq GmbH	Compositions comprenant un ligand de liaison de récepteur cannabinoïde
CA3045733C (fr) *	2016-12-22	2024-01-16	Novaliq Gmbh	Compositions comprenant du tacrolimus pour le traitement de maladies oculaires inflammatoires intraoculaires
DK3399962T3 (da) *	2016-12-23	2020-09-07	Novaliq Gmbh	Oftalmisk sammensætning til behandling af tør øjensygdom
CN110520097B (zh)	2017-01-06	2023-10-27	帕尔维拉治疗股份有限公司	Mtor抑制剂的无水组合物及其使用方法
MX388460B (es) *	2017-04-21	2025-03-20	Dermaliq Therapeutics Inc	Composiciones de yodo.
US10717691B2 (en)	2017-05-05	2020-07-21	Novaliq Gmbh	Process for the production of semifluorinated alkanes
CN110650734B (zh) *	2017-05-12	2024-11-15	诺瓦利克有限责任公司	治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物
IL273531B2 (en)	2017-09-27	2024-05-01	Novaliq Gmbh	Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11896559B2 (en)	2017-10-04	2024-02-13	Novaliq Gmbh	Opthalmic compositions comprising F6H8
EP3758676A1 (fr)	2018-03-02	2021-01-06	Novaliq GmbH	Compositions pharmaceutiques contenant du nébivolol
JP2021522219A (ja)	2018-04-27	2021-08-30	ノバリックゲーエムベーハー	緑内障の治療のためのタフルプロストを含む眼科用組成物
JP2021530463A (ja)	2018-07-02	2021-11-11	パルヴェラセラピューティクス、インク．	ｍＴＯＲ阻害剤の無水組成物および使用方法
KR20210080388A (ko) *	2018-09-22	2021-06-30	노바리크 게엠베하	안구 표면 손상 및 건조 증상 치료를 위한 안약 조성물
US12029757B2 (en)	2018-09-27	2024-07-09	Dermaliq Therapeutics, Inc.	Lipid barrier repair
WO2020074697A1 (fr)	2018-10-12	2020-04-16	Novaliq Gmbh	Composition ophtalmique pour le traitement d'une maladie oculaire sèche
US20220008397A1 (en) *	2019-01-21	2022-01-13	Novaliq Gmbh	Pharmaceutical composition for the treatment of ocular neovascularisation
WO2020165132A1 (fr)	2019-02-13	2020-08-20	Novaliq Gmbh	Compositions et procédés pour le traitement de la néovascularisation oculaire
EP3975989A1 (fr)	2019-05-24	2022-04-06	Novaliq GmbH	Composition ophtalmique pour le traitement d'une allergie oculaire
WO2021044045A1 (fr)	2019-09-06	2021-03-11	Novaliq Gmbh	Composition ophtalmique pour le traitement de l'uvéite
WO2021048803A1 (fr)	2019-09-13	2021-03-18	Minas Coroneo	Distributeur de gouttes oculaires
US20210308154A1 (en)	2020-03-24	2021-10-07	Hovione Scientia Limited	Methods and Compositions for Treating Meibomian Gland Dysfunction
US11191751B1 (en) *	2020-10-08	2021-12-07	Ads Therapeutics Llc	Topical ophthalmological atropine free base compositions
IL322635A (en) *	2023-02-13	2025-10-01	Novaliq Gmbh	Ophthalmic preparation for eye surgery in patients with ocular surface disease
AU2023270196B2 (en) *	2023-11-20	2025-06-26	Dyer, Gordon Wayne DR	Method of Arthropod Egress

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839342A (en)	1987-09-03	1989-06-13	University Of Georgia Research Foundation, Inc.	Method of increasing tear production by topical administration of cyclosporin
WO1989001772A1 (fr)	1987-09-03	1989-03-09	University Of Georgia Research Foundation, Inc.	Composition de cyclosporine oculaire
US5874481A (en) *	1995-06-07	1999-02-23	Alliance Pharmaceutical Corp.	Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
DE19536504C2 (de) *	1995-09-29	1999-09-23	H Meinert	Verwendung fluorierter Alkane
DE19861012A1 (de) *	1998-03-18	1999-09-30	Pharm Pur Gmbh	Behandlungsmittel für die Ophthalmologie
AU777915B2 (en) *	1999-04-30	2004-11-04	Sucampo Ag	Use of macrolide compounds for the treatment of dry eye
DE19938668B4 (de) *	1999-08-14	2006-01-26	Bausch & Lomb Inc.	Tränenersatzmittel
US20030018044A1 (en) *	2000-02-18	2003-01-23	Peyman Gholam A.	Treatment of ocular disease
CA2563544A1 (fr) *	2004-04-19	2005-10-27	Centre National De La Recherche Scientifique (C.N.R.S.)	Complements de surfactant pulmonaire
MXPA06014425A (es) *	2004-06-08	2007-05-23	Ocularis Pharma Inc	Composiciones oftalmicas hidrofobas y metodo de uso.
DE102007055046A1 (de) *	2007-11-19	2009-05-28	Fluoron Gmbh	Infusionslösung
DK2110126T3 (da)	2008-04-18	2012-02-27	Novaliq Gmbh	Inhalations- og instillationsanvendelse af semifluorerede alkaner som aktiv bestanddel-bærere inden for det intrapulmonale område

2009
- 2009-12-14 EP EP09015423A patent/EP2335735A1/fr not_active Withdrawn
2010
- 2010-12-13 BR BR112012014190A patent/BR112012014190B8/pt active IP Right Grant
- 2010-12-13 PL PL10790775T patent/PL2512515T3/pl unknown
- 2010-12-13 JP JP2012542577A patent/JP5663595B2/ja active Active
- 2010-12-13 ES ES10790775.0T patent/ES2449308T3/es active Active
- 2010-12-13 WO PCT/EP2010/069495 patent/WO2011073134A1/fr not_active Ceased
- 2010-12-13 KR KR1020167023214A patent/KR101722039B1/ko active Active
- 2010-12-13 DK DK10790775.0T patent/DK2512515T3/en active
- 2010-12-13 IN IN3128DEN2012 patent/IN2012DN03128A/en unknown
- 2010-12-13 BR BR122017018955-7A patent/BR122017018955B1/pt active IP Right Grant
- 2010-12-13 CA CA2776860A patent/CA2776860C/fr active Active
- 2010-12-13 EP EP10790775.0A patent/EP2512515B1/fr active Active
- 2010-12-13 PT PT107907750T patent/PT2512515E/pt unknown
- 2010-12-13 AU AU2010333039A patent/AU2010333039B2/en active Active
- 2010-12-13 CA CA2941956A patent/CA2941956C/fr active Active
- 2010-12-13 US US13/513,886 patent/US8614178B2/en active Active
- 2010-12-13 KR KR1020127018066A patent/KR101652714B1/ko active Active
- 2010-12-13 CN CN201080055507.7A patent/CN102652022B/zh active Active
- 2010-12-13 MX MX2012006720A patent/MX2012006720A/es active IP Right Grant
- 2010-12-13 BR BR122020020872-4A patent/BR122020020872B1/pt active IP Right Grant
2014
- 2014-10-01 JP JP2014203406A patent/JP6096731B2/ja active Active
2016
- 2016-12-22 JP JP2016248533A patent/JP6397472B2/ja active Active
2018
- 2018-08-31 JP JP2018163569A patent/JP2019006803A/ja active Pending
- 2018-12-28 JP JP2018248700A patent/JP6731039B2/ja active Active

Also Published As

Publication number	Publication date
JP2017078086A (ja)	2017-04-27
EP2335735A1 (fr)	2011-06-22
JP2015028064A (ja)	2015-02-12
JP2019006803A (ja)	2019-01-17
JP2019070003A (ja)	2019-05-09
KR101722039B1 (ko)	2017-03-31
CN102652022A (zh)	2012-08-29
PT2512515E (pt)	2014-03-04
JP6731039B2 (ja)	2020-07-29
AU2010333039B2 (en)	2014-08-28
JP2013513586A (ja)	2013-04-22
DK2512515T3 (en)	2014-03-10
ES2449308T3 (es)	2014-03-19
BR112012014190B1 (pt)	2021-03-02
PL2512515T3 (pl)	2014-05-30
BR122020020872B1 (pt)	2021-09-08
MX2012006720A (es)	2012-07-30
BR112012014190A2 (pt)	2016-05-31
JP5663595B2 (ja)	2015-02-04
HK1172269A1 (en)	2013-04-19
KR20120115977A (ko)	2012-10-19
EP2512515A1 (fr)	2012-10-24
CA2776860C (fr)	2016-10-25
BR122017018955B1 (pt)	2022-03-08
JP6096731B2 (ja)	2017-03-15
EP2512515B1 (fr)	2013-12-25
US8614178B2 (en)	2013-12-24
KR101652714B1 (ko)	2016-09-01
AU2010333039A1 (en)	2012-07-12
WO2011073134A1 (fr)	2011-06-23
CA2941956A1 (fr)	2011-06-23
CA2776860A1 (fr)	2011-06-23
CN102652022B (zh)	2014-12-17
JP6397472B2 (ja)	2018-09-26
CA2941956C (fr)	2018-09-04
BR112012014190B8 (pt)	2021-05-25
KR20160105533A (ko)	2016-09-06
US20120244177A1 (en)	2012-09-27

Publication	Publication Date	Title
IN2012DN03128A (fr)	2015-09-18
WO2015106128A3 (fr)	2015-10-08	Agents d'arni modifiés
NZ708593A (en)	2018-01-26	Novel pyrazole derivative
MY175800A (en)	2020-07-09	Combination treatment of cancer
EP4342540A3 (fr)	2024-05-29	Dérivés hétérocyclyle substitués en tant qu'inhibiteurs de cdk
EP4292662A3 (fr)	2024-02-21	Inhibiteurs d'indoles mcl-1 substitués
WO2015070224A3 (fr)	2015-08-13	Polythérapie comprenant un inhibiteur de mdm2 et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers
CU20160109A7 (es)	2017-02-02	Compuestos de indazol como inhibidores de irak4
WO2011113802A3 (fr)	2012-08-02	Composés d'imidazopyridine, compositions et procédés d'utilisation
EA033343B1 (ru)	2019-09-30	Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
MX2013012776A (es)	2013-11-21	Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina.
BR112014000792A2 (pt)	2017-10-31	compostos de piperidinila para uso como inibidores da tanquirase
EP4342537A3 (fr)	2024-07-03	Compositions d'alcane semifluoré
WO2012027065A3 (fr)	2012-05-10	Polythérapie pour traiter des maladies
EP4414376A3 (fr)	2024-11-06	Nouveau depsipeptide et ses utilisations
CO2019011877A2 (es)	2020-01-17	Nuevos derivados de pirazol bicíclicos
EP4403552A3 (fr)	2024-10-16	Inhibiteurs de hsp90 c-terminaux
WO2014028931A3 (fr)	2014-10-09	Composés et procédés de traitement d'infections microbiennes gastro-intestinales de mammifère
EP3216798A3 (fr)	2017-10-25	Composés kétolides
MX341220B (es)	2016-08-10	Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
MX2012015100A (es)	2013-05-01	Compuestos y composiciones de heteroarilo como inhibidores de cinasa de proteina.
CL2012003521A1 (es)	2013-02-15	Derivado piperidino (r)-n-((r)-1-((3s-4s)-4-(4-clorofenil)-3,4-dihidroxi-3-metilpiperidin-1-il)-3-metil-1-oxobutan-2-il)-3,3-difluorociclopentanocarboxamida, modulador receptor quimiocinas; composicion farmaceutica; y uso del compuesto y su composicion en enfermedades inflamatorias y autoinmunitarias, entre otras.
MX2024010625A (es)	2024-09-05	Compuestos antibioticos, metodos de fabricacion de los mismos, composiciones farmaceuticas conteniendo los mismos y usos de los mismos.
IN2014CN02908A (fr)	2015-07-03
EP2361083A4 (fr)	2013-11-20	Composition pour le traitement du tissu épithélial